Leanne Kilzer
Family · Grand Forks, NDNPI 1306464219
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,905 of the $2,740 with a category attached, or 69.5%. Medtronic accounts for 81.8% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $2,319, more than ten times the $17 reported in 2022. Among family clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $124.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- AstraZeneca$132
- Biogen$98
- Eisai Inc.$81
- Springworks Therapeutics, Inc.$77
- SK Life Science, Inc.$50
- plus $61 from 3 others
What the payments were for
- Travel & lodging$1,90570%
- Food & beverage$83530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 12 | $2,241 |
| AstraZeneca(2 entities) | 2 | $132 |
| Biogen | 1 | $98 |
| Eisai Inc. | 2 | $81 |
| Springworks Therapeutics, Inc. | 1 | $77 |
| SK Life Science, Inc. | 1 | $50 |
| UCB, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| AbbVie | 1 | $17 |
How this compares
$2,740 in reported general payments places this provider in the 90th percentile of 496 family providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KeppraLevetiracetam | 18 | $45,436 |
| QuliptaAtogepant | 25 | $28,881 |
| Nurtec OdtRimegepant Sulfate | 17 | $26,944 |
| Emgality PenGalcanezumab-Gnlm | 32 | $25,365 |
| EliquisApixaban | 34 | $20,796 |
| XcopriCenobamate | 18 | $15,852 |
| Aimovig AutoinjectorErenumab-Aooe | 14 | $9,900 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 138 | $4,825 |
| Levetiracetam | 167 | $4,589 |
| DilantinPhenytoin Sodium Extended | 29 | $3,523 |
| Primidone | 74 | $2,465 |
| Gabapentin | 88 | $2,236 |
| Memantine Hcl | 24 | $2,219 |
| Divalproex Sodium ErDivalproex Sodium | 27 | $2,205 |
| Lamotrigine | 100 | $1,788 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta | $17 | $28,88125 claims |
| SK Life Science, Inc.Xcopri | $50 | $15,85218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 496 family providers in North Dakota.
Other family in Grand Forks
- Coralyn Jensen KurtzGrand Forks$12K
- Paula RickeGrand Forks$9K
- Lynde QuirkGrand Forks$5K
- Nicole RobinsonGrand Forks$2K
- Nicole StrausGrand Forks$2K
- Christina DahlJamestown$26K
- Courtney WoodburyBismarck$8K
- Monica GoetzBismarck$8K
- Danielle EidenschinkFargo$6K
- Chantel HillestadMinot$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.